Content

Events
About

Scale-Up and Manufacturing of Regenerative Medicine

Amber Scorah | 09/28/2011

When introducing a regenerative medicine cell based product to a commercial setting, there are a number of things to take into consideration to ensure a commercially viable and safe product for patient use. In this podcast, William Fodor, Director of Translational Sciences, Cell Therapy Group, gives some great insights into the commercial manufacturing scale-up process of cell therapies.


 

Have Your Say
Rate this feature and give us your feedback in the comments section below

Upcoming Events


DigIT Pharma & Health 2024

September 10 - 12, 2024
Düsseldorf, Germany
Register Now | View Agenda | Learn More

MORE EVENTS